Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • Log out
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Human and Escherichia coliβ-Glucuronidase Hydrolysis of Glucuronide Conjugates of Benzidine and 4-Aminobiphenyl, and their Hydroxy Metabolites

Terry V. Zenser, Vijaya M. Lakshmi and Bernard B. Davis
Drug Metabolism and Disposition September 1999, 27 (9) 1064-1067;
Terry V. Zenser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vijaya M. Lakshmi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernard B. Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Individuals exposed to carcinogenic aromatic amines excrete arylamine N- and O-glucuronide metabolites. This study assessed the susceptibility of selected glucuronides to hydrolysis by human and Escherichia coliβ-glucuronidase. N- or O-glucuronides were prepared with the following aglycones: benzidine,N-acetylbenzidine,N′-hydroxy-N-acetylbenzidine,N-hydroxy-N-acetylbenzidine,N-hydroxy-N,N′-diacetylbenzidine, 3-hydroxy-N,N′-diacetylbenzidine, 3-hydroxy-benzidine, 4-aminobiphenyl, N-hydroxy-4-aminobiphenyl, andN-hydroxy-N-acetyl-4-aminobiphenyl. The3H- and 14C-labeled glucuronides were prepared with human or rat liver microsomes using UDP-glucuronic acid as cosubstrate. Each of the 10 glucuronides (6–12 μM) was incubated at pH 5.5 or 7.0 with either human recombinant (pure) or E. coli (commercial preparation) β-glucuronidase for 30 min at 37°C. Hydrolysis was measured by HPLC. Reaction conditions were optimized, using the O-glucuronide ofN-hydroxy-N,N′-diacetylbenzidine. Both enzymes preferentially hydrolyzed O-glucuronides overN-glucuronides and distinguished between structural isomers. With E. coli β-glucuronidase at pH 7.0, selectivity was demonstrated by the complete hydrolysis ofN-hydroxy-N-acetyl-4-aminobiphenylO-glucuronide in the presence ofN-acetylbenzidine N-glucuronide, which was not hydrolyzed. Metabolism by both enzymes was completely inhibited by the specific β-glucuronidase inhibitor saccharic acid-1,4-lactone (0.5 mM). The concentration of human β-glucuronidase necessary to achieve significant hydrolysis of glucuronides was substantially more than the amount of enzyme reported previously to be present in urine under either normal or pathological conditions. The bacterial enzyme may hydrolyze O-glucuronides, but notN-glucuronides, in urine at neutral pH. Thus, the nonenzymatic hydrolysis of N-glucuronides by acidic urine is likely a more important source of free amine than enzymatic hydrolysis.

Aromatic amines cause bladder cancer in humans. Exposure to aromatic amines can occur in chemical, dye, and rubber industries (Doll and Peto, 1981), from cigarette smoke (Ross et al., 1988), and from motor vehicle exhaust (Guerin and Buchanan, 1988). Proposed mechanisms of aromatic amine initiation of bladder cancer are thought to involve multiple organs (i.e., liver, kidney, and bladder) and pathways (i.e., N- andO-oxidation, peroxidation, N- andO-acetylation, and glucuronidation; Kadlubar et al., 1977;Lakshmi et al., 1998). A recent study has demonstrated the presence ofN-glucuronides of benzidine and N-acetylbenzidine in urine from workers exposed to benzidine (Rothman et al., 1997). Urine has been proposed to play an important role in initiation of carcinogenesis. Considering the routes of possible aromatic amine exposure and the site of tumor formation, urine serves as a means of transporting aromatic amines and their metabolites to the bladder lumen. In addition, acidic urine hydrolyzes N-glucuronides of aromatic amines (Babu et al., 1992, 1993). Urine also contains β-glucuronidase, which can hydrolyze glucuronide metabolites. The role of β-glucuronidase in aromatic amine bladder carcinogenesis is not known.

Human β-glucuronidase is mainly found in the lysosomes and microsomes of normal tissues, with plasma levels of enzyme quite low. β-Glucuronidase is normally excreted in urine with cells of the urinary tract the primary source of enzyme (Wachstein, 1955; Bank and Bailine, 1965). Increased urinary levels of enzyme are observed in conditions that affect the urinary tract, such as acute renal necrosis, active pyelonephritis, and cancer of the kidney and bladder (Gonick et al., 1973). The enzyme has a characteristic acidic pH optimum. In contrast, Escherichia coli β-glucuronidase has a much higher pH optimum (Ho and Ho, 1985). E. coliβ-glucuronidase may also be present in urine due to urinary tract infection. The susceptibility of N- andO-glucuronides of aromatic amines to hydrolysis by β-glucuronidase has not been rigorously tested. This study usedE. coli β-glucuronidase and pure human recombinant β-glucuronidase to assess metabolism of 10 N- andO-glucuronides of benzidine and 4-aminobiphenyl and their hydroxy metabolites. The experiments demonstrate selectivity in hydrolysis of these glucuronides by both β-glucuronidases.

Materials and Methods

The following compounds were used as substrates for the synthesis of glucuronides: benzidine, N-acetylbenzidine,N′-hydroxy-N-acetylbenzidine,N-hydroxy-N-acetylbenzidine,N-hydroxy-N,N′-diacetylbenzidine, 3-hydroxy-N,N′-diacetylbenzidine, 3-hydroxy-benzidine, 4-aminobiphenyl, N-hydroxy-4-aminobiphenyl, andN-hydroxy-N-acetyl-4-aminobiphenyl. These compounds were purchased from Sigma Chemical Co. (St. Louis, MO), Midwest Research Institute (Kansas City, MO), or synthesized as described previously (Lakshmi et al., 1990, 1996; Babu et al., 1995,1996). N- and O-Glucuronides were prepared with human hepatic microsomes (Zenser et al., 1978), except for 3-hydroxy-benzidine and 3-hydroxy-N,N′-diacetylbenzidine, which used microsomes from β-naphthoflavone-treated rats (Lakshmi et al., 1997). Glucuronides were radiolabeled with either14C-UDP-glucuronic acid (279 mCi/mmol; ICN, Irvine, CA), or for benzidine and N-acetylbenzidine with3H-benzidine (180 mCi/mmol; Chemsyn, Lenexa, KS;Babu et al., 1993, 1995). Incubation mixtures were extracted with ethyl acetate to remove the unreacted substrate and then withn-butanol to remove the glucuronide. The following radiochemical purity of the glucuronides was determined by HPLC: 77% benzidine, 93% N-acetylbenzidine, 84%N′-hydroxy-N-acetylbenzidine, 66%N-hydroxy-N-acetylbenzidine, 98%N-hydroxy-N,N′-diacetylbenzidine, 100% 3-hydroxy-N,N′diacetylbenzidine, 85% 3-hydroxy-benzidine, 55% 4-aminobiphenyl, 95% N-hydroxy-4-aminobiphenyl, and 98% N-hydroxy-N-acetyl-4-aminobiphenyl. The major impurity was the starting material, either14C-UDP-glucuronic acid or3H-aglycone. Glucuronides were identified by hydrolysis to their aglycone by treatment with acid or β-glucuronidase as described previously (Babu et al., 1995, 1996). All of the aromatic amine substrates used in this study have been incubated with liver microsomes and shown to yield a singleN- or O-glucuronide product that was rigorously characterized (Babu et al., 1992, 1993, 1995; Ciotti et al., 1999). Diglucuronide conjugates were not detected.

β-Glucuronidase type VII-A from E. coli (11.3 Fishman U/μg) was obtained from Sigma Chemical Co. (St. Louis, MO) and exhibited 4,800 units of activity per μg at pH 7.0, using standardized conditions with 4-methylumbelliferyl β-glucuronide as substrate (Watanabe et al., 1990). Pure human recombinant β-glucuronidase was prepared as described previously (Watanabe et al., 1990) and exhibited 5,000 U/μg at pH 4.8 with 4-methylumbelliferyl β-glucuronide as substrate. With 4-methylumbelliferyl β-glucuronide, human β-glucuronidase activity at pH 5.5 and 7.0 is 66 and 17%, respectively, of that at pH 4.8. E. coli β-glucuronidase activity at pH 5.5 is 84% of that seen at pH 7.0.

To assess β-glucuronidase hydrolysis of the aromatic amineN- or O-glucuronides, the glucuronides (6–12 μM) were dissolved in 100 mM phosphate buffer at pH 5.5 or 7.0 and incubated in a total volume of 0.025 ml for 30 min at 37°C with the indicated amount of β-glucuronidase (Table1). Sufficient enzyme was added to achieve partial hydrolysis of theN-hydroxy-N,N′-diacetylbenzidineO-glucuronide. Incubations were stopped by adding 0.025 ml of methanol and adjusting the pH to 9.0 with 1 N NaOH. Samples were immediately frozen at −70°C for analysis by HPLC.

View this table:
  • View inline
  • View popup
Table 1

Human and E. coli β-glucuronidase hydrolysis of glucuronide conjugates of benzidine and 4-aminobiphenyl and their hydroxy metabolites at pH 5.5 and 7.0

Hydrolysis was assessed with a Beckman HPLC using System Gold software and consisted of a 5 μm, 4.6 × 150 mm C-18 ultrasphere column attached to a guard column (RP-18, 7 μm 15 × 3.2 mm; Brownlee Columns, Perkin Elmer, Norwalk, CT). The solvent system contained 5% methanol in 20 mM phosphate buffer (pH 7.0), 0 to 5 min; 5 to 80%, 5 to 17 min; 80 to 5%, 20 to 25 min; flow rate 1 ml/min. Radioactivity in HPLC eluents was measured using a FLO-ONE radioactive flow detector (Packard Instrument Company, Downers Grove, IL). Blanks were incubated without enzyme for 30 min. For all 10 glucuronides examined, the recovery of total radioactivity in the enzyme-treated samples was at least 90% that observed in the nontreated samples. To calculate the amount of product formed by β-glucuronidase, the percentage of substrate hydrolyzed by enzyme was subtracted from the values observed in the blank and multiplied by the picomoles of substrate added.

Results

Incubation conditions for human and E. coliβ-glucuronidase were optimized usingN-hydroxy-N,N′-diacetylbenzidineO-glucuronide as substrate. The concentration-dependent metabolism of this O-glucuronide was assessed for human β-glucuronidase at pH 7.0 in Fig. 1. Metabolism was concentration-dependent from 0 to 7,000 U of enzyme activity. The loss of substrate correlated with the recovery of product. When the concentration ofN-hydroxy-N,N′-diacetylbenzidineO-glucuronide was increased from 12 to 24 μM with 5,500 U of enzyme activity, nearly twice the amount of hydrolysis was observed. This suggests that human β-glucuronidase is not saturated at this substrate concentration. Similar results were observed with theE. coli enzyme. Both enzymes have different pH optimums. This is illustrated in Fig. 2. Although the human enzyme has higher activity at pH 5.5, the bacterial enzyme has higher activity at pH 7.0. Subsequent incubations were at either pH 5.5 or 7.0 and contained enzyme sufficient to achieve partial metabolism of N-hydroxy-N,N′-diacetylbenzidineO-glucuronide. In addition, neither 0.01 mMN-acetylbenzidine nor UDP-glucuronic acid altered hydrolysis of this O-glucuronide.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Concentration-dependent hydrolysis of N-hydroxy-N,N′-diacetylbenzidine O-glucuronide by human β-glucuronidase.

The indicated units of enzyme activity were incubated with 12 μMO-glucuronide at pH 7.0 for 30 min and analyzed by HPLC as described in Materials and Methods.

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

Effect of pH on hydrolysis of N-hydroxy-N,N′-diacetylbenzidine O-glucuronide by human and E. coli β-glucuronidase.

O-Glucuronide (12 μM) was incubated with 1,000 and 21 units of human and E. coli enzyme, respectively, and analyzed by HPLC as described in Materials and Methods.

Human β-glucuronidase demonstrated selective metabolism ofN- and O-glucuronides of benzidine and 4-aminobiphenyl (Table 1). At the acidic pH, near its pH optimum, only the O-glucuronides were analyzed because theN-glucuronides are acid labile (Babu et al., 1993, 1995,1996). Using the same amount of enzyme, glucuronide conjugates of the hydroxamic acids, N-hydroxy-N-acetylbenzidine,N-hydroxy-N,N′-diacetylbenzidine, andN-hydroxy-N-acetyl-4-aminobiphenyl, were metabolized to a similar extent. Considerably more metabolism was observed with the ring oxidation products, 3-hydroxy-benzidine and 3-hydroxy-N,N′-diacetylbenzidine. This preference for metabolism of O-glucuronides on the ring compared to the nitrogen was also observed at pH 7.0. No hydrolysis of any of the primary amine N-glucuronides, benzidine,N-acetylbenzidine, and 4-aminobiphenyl, was observed at pH 7.0. In contrast, considerable metabolism of theN-glucuronides of the N-hydroxyarylamines,N′-hydroxy-N-acetylbenzidine and N-hydroxy-4-aminobiphenyl, were observed. A large range of hydrolysis was observed for N- and O-glucuronides of benzidine and 4-aminobiphenyl metabolites at pH 7.0.

Selective metabolism of these N- andO-glucuronides was also observed with E. coliβ-glucuronidase (Table 1). Because the bacterial enzyme more efficiently metabolized O-glucuronides than the human enzyme, fewer units of enzyme were required to achieve significant hydrolysis. At pH 7.0, the highest rates of hydrolysis were observed for the hydroxamic acids with little or no metabolism observed with the ring hydroxy products. Although this preference for metabolism ofO-glucuronides on the nitrogen compared to the ring was also observed at pH 5.5, considerable more metabolism of ring hydroxy products was observed at pH 5.5. Saccharic acid-1,4-lactone (0.5 mM), a specific inhibitor of β-glucuronidase, caused complete inhibition of metabolism by both the bacterial and human enzymes. At pH 7.0, the bacterial enzyme exhibited little or no hydrolysis forN-glucuronides of both primary andN-hydroxyarylamines. If the amount of bacterial enzyme was increased 100-fold, significant metabolism of benzidine,N-acetylbenzidine, and 4-aminobiphenylN-glucuronides was observed. Overall, at the concentrations used in Table 1, E. coli β-glucuronidase hydrolyzed fewer substrates than the human enzyme at neutral pH.

To demonstrate the selectivity of β-glucuronidase metabolism, 40 U ofE. coli enzyme were added to an incubation at pH 7.0 that contained 12 μM the N-glucuronide ofN-acetylbenzidine and 12 μM the O-glucuronide of N-hydroxy-N-acetyl-4-aminobiphenyl. In this combined incubation, nearly complete hydrolysis of theO-glucuronide (95%), but no hydrolysis of theN-glucuronide, was detected. Similar results were also observed with human β-glucuronidase. This also demonstrates that the lack of hydrolysis of N-glucuronides is not due to the presence of nonradioactive substances, which are interfering with metabolism.

Discussion

These experiments have demonstrated selective hydrolysis ofN- and O-glucuronides of benzidine and 4-aminobiphenyl and their hydroxy metabolites by both human andE. coli β-glucuronidases. Both enzymes preferentially hydrolyzed O-glucuronides over N-glucuronides and distinguished between the structural isomersN-hydroxy-N,N′-diacetylbenzidine and 3-hydroxy-N,N′-diacetylbenzidine, andN′-hydroxy-N-acetylbenzidine andN-hydroxy-N-acetylbenzidine. The human enzyme distinguished between N-glucuronides of primary compared toN-hydroxyarylamines. This enzyme also preferred hydrolyzing ring O-glucuronides. In contrast, the bacterial enzyme demonstrated little metabolism of N-glucuronides and preferred O-glucuronides of hydroxamic acids. Thus, the selectivity for metabolizing these glucuronides is quite different for human and E. coli β-glucuronidases.

Purity of the N-glucuronides did not contribute to their lack of metabolism by β-glucuronidases. N-AcetylbenzidineN′-glucuronide and 4-aminobiphenyl N-glucuronide are 93 and 55% pure, respectively, but neither is hydrolyzed by β-glucuronidase. The N-glucuronide ofN-hydroxy-4-aminobiphenyl is 95% pure and is actively hydrolyzed by human, but not E. coli, β-glucuronidase. In addition, neither 0.01 mM N-acetylbenzidine nor UDP-glucuronic acid altered hydrolysis of the O-glucuronide of N-hydroxy-N,N′-diacetylbenzidine. The combination experiment assessing O-glucuronide hydrolysis in the presence of N-acetylbenzidine N′-glucuronide further demonstrates that nonradioactive substances are not interfering and that N-glucuronides are not false substrates inhibiting hydrolysis in this manner. Thus, the results are consistent withN-glucuronides not being substrates for β-glucuronidases.

The concentrations of human β-glucuronidase used in these experiments are 140 to over 5000 times more than the normal range reported for this enzyme in urine (Glaser and Sly, 1973). Even under pathological conditions of the urinary tract, such as bladder cancer, which causes a 30% increase in urinary β-glucuronidase activity (Paigen et al., 1984), the concentration of enzyme does not reach values required for metabolism. In contrast, E. coli β-glucuronidase may metabolize O-glucuronides of these hydroxamic acids in urine at neutral pH (Harris et al., 1978). The bacterial enzyme would not be expected to hydrolyze N-glucuronides in urine at neutral pH. To allow comparison of β-glucuronidase from the pure human and commercial bacterial preparation, both were assayed using 4-methylumbelliferyl β-glucuronide as substrate under standard conditions, and corresponding units were used to express activity (Watanabe et al., 1990). The results suggest that the bacterial enzyme may be much more efficient in hydrolyzing hydroxamic acid O-glucuronides than the human enzyme.

Although the N-glucuronides are poor substrates for β-glucuronidase, these conjugates are quite acid-labile. For theN-glucuronides of benzidine, N-acetylbenzidine, 4-aminobiphenyl, and N-hydroxy-4-aminobiphenyl, theirT1/2 values at pH 5.5 range from 5 to 30 min (Babu et al., 1993, 1995, 1996). In contrast, theT1/2 values at pH 7.4 extend from 100 to over 200 min for the same N-glucuronides (Babu et al., 1993,1995, 1996). This acid lability has been proposed to contribute to the carcinogenic process by causing N-glucuronides to be hydrolyzed to their parent amines in acidic urine and by accumulation of the amines in the bladder epithelium. Amines are then activated to form DNA adducts, which initiate carcinogenesis. This hypothesis is supported by recent experiments evaluating benzidine andN-acetylbenzidine metabolism in workers exposed to benzidine. In postworkshift urine, pH was inversely correlated with the proportions of benzidine and N-acetylbenzidine present as free compounds (Rothman et al., 1997). When controlling for internal dose, individuals with urine pH < 6 had a 10-fold higher DNA adduct level,N′-(3′-monophospho-deoxyguanosin-8-yl)-N-acetylbenzidine, in their exfoliated bladder cells compared with subjects with urine pH ≥ 7. This DNA adduct produces genotoxic lesions, causing mutations in various bacterial and mammalian test systems in vitro (Beland et al., 1983; Heflich et al., 1986; Melchior Jr et al., 1994) and mutations in oncogenes of tumors induced in vivo by benzidine (Fox et al., 1990). Thus, although selective hydrolysis of N- andO-glucuronides was demonstrated by both human and E. coli β-glucuronidases, neither enzyme efficiently metabolizedN-glucuronides at neutral pH. These results suggest that nonenzymatic hydrolysis of N-glucuronides by acidic urine is an important source of free amine in the bladder lumen of exposed workers.

Acknowledgments

We thank Dr. William S. Sly and Jeffrey H. Grubb for the pure human β-glucuronidase, advice on analysis of β-glucuronidase activity, and for critically reviewing the manuscript. We also thank Cindee Rettke and Priscilla DeHaven for excellent technical assistance.

Footnotes

  • Send reprint requests to: Terry V. Zenser, Ph.D., Veterans Administration Medical Center (11G-JB), St. Louis, MO 63125-4199. E-mail: zensertv{at}slu.edu

  • This work was supported by the Department of Veterans Affairs (T.V.Z., B.B.D.) and National Cancer Institute Grant CA72613 (T.V.Z.).

    • Received February 9, 1999.
    • Accepted April 29, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics

References

  1. ↵
    1. Babu SR,
    2. Lakshmi VM,
    3. Hsu FF,
    4. Kane KE III,
    5. Zenser TV,
    6. Davis BB
    (1993) N-Acetylbenzidine-N′-glucuronidation by human, dog, and rat liver. Carcinogenesis 14:2605–2611.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Babu SR,
    2. Lakshmi VM,
    3. Hsu FF,
    4. Zenser TV,
    5. Davis BB
    (1992) Role of N-glucuronidation in benzidine-induced bladder cancer in dog. Carcinogenesis 13:1235–1240.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Babu SR,
    2. Lakshmi VM,
    3. Hsu FF,
    4. Zenser TV,
    5. Davis BB
    (1995) Glucuronidation of N-hydroxy metabolites of N-acetylbenzidine. Carcinogenesis 16:3069–3074.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Babu SR,
    2. Lakshmi VM,
    3. Huang GP,
    4. Zenser TV,
    5. Davis BB
    (1996) Glucuronide conjugates of 4-aminobiphenyl and its N-hydroxy metabolites: pH stability and synthesis by human and dog liver. Biochem Pharmacol 51:1679–1687.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Bank N,
    2. Bailine SH
    (1965) Urinary beta-glucuronidase activity in patients with urinary tract infection. N Engl J Med 272:70–75.
  6. ↵
    1. Beland FA,
    2. Beranek DT,
    3. Dooley KL,
    4. Heflich RH,
    5. Kadlubar FF
    (1983) Arylamine-DNA adducts in vitro and in vivo: Their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environ Health Perspect 49:125–134.
    OpenUrlCrossRefPubMed
  7. ↵
    Ciotti M, Lakshmi VM, Nikhil B, Davis BB, Owens IS and Zenser TV (1999) Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides.Carcinogenesis, in press..
  8. ↵
    1. Doll R,
    2. Peto R
    (1981) The Causes of Cancer. (Oxford University Press, New York).
  9. ↵
    1. Fox TR,
    2. Schumann AM,
    3. Watanabe PG,
    4. Yano BL,
    5. Maher VM,
    6. McCormick JJ
    (1990) Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens. Cancer Res 50:4014–4019.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Glaser JH,
    2. Sly WS
    (1973) β-Glucuronidase deficiency mucopolysaccharidosis: Methods for enzymatic diagnosis. J Lab Clin Med 82:969–977.
    OpenUrlPubMed
  11. ↵
    1. Gonick HC,
    2. Kramer HJ,
    3. Schapiro AE
    (1973) Urinary β-glucuronidase activity in renal disease. Arch Intern Med 132:63–69.
    OpenUrlCrossRefPubMed
  12. ↵
    1. King CM,
    2. Romano LJ,
    3. Schuetzle D
    1. Guerin MR,
    2. Buchanan MV
    (1988) Environmental exposure to N-aryl compounds. in Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes, eds King CM, Romano LJ, Schuetzle D (Elsevier Science Publishing Co. Inc., New York), pp 37–45.
  13. ↵
    1. Harris RE,
    2. Thomas VL,
    3. Underwood JM,
    4. Gaudot F
    (1978) A comparison of two indirect methods for localizing the site of urinary infection: Beta glucuronidase levels and the presence of antibody-coated bacteria. Am J Obstet Gynecol 131:647–649.
    OpenUrlPubMed
  14. ↵
    1. Heflich RH,
    2. Morris SM,
    3. Beranek DT,
    4. McGarrity LJ,
    5. Chen JJ,
    6. Beland FA
    (1986) Relationships between the DNA adducts and the mutations and sister-chromatid exchanges produced in Chinese hamster ovary cells by N-hydroxy-2-aminofluorene, N-hydroxy-N′-acetylbenzidine and 1-nitrosopyrene. Mutagenesis 1:201–206.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Ho Y,
    2. Ho K
    (1985) Differential quantitation of urinary β-glucuronidase of human and bacterial origins. J Urol 134:1227–1230.
    OpenUrlPubMed
  16. ↵
    1. Kadlubar FF,
    2. Miller JA,
    3. Miller EC
    (1977) Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Res 37:805–814.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Lakshmi VM,
    2. Mattammal MB,
    3. Spry LA,
    4. Kadlubar FF,
    5. Zenser TV,
    6. Davis BB
    (1990) Metabolism and disposition of benzidine in the dog. Carcinogenesis 11:139–144.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Lakshmi VM,
    2. Zenser TV,
    3. Davis BB
    (1997) Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N′-diacetylbenzidine, Drug Metab Dispos 25:481–488.
  19. ↵
    1. Lakshmi VM,
    2. Zenser TV,
    3. Davis BB
    (1998) N′-(3′-monophospho-deoxyguanosin-8-yl)-N-acetylbenzidine formation by peroxidative metabolism. Carcinogenesis 19:911–917.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Lakshmi VM,
    2. Zenser NT,
    3. Hsu FF,
    4. Mattammal MB,
    5. Zenser TV,
    6. Davis BB
    (1996) NADPH-dependent oxidation of benzidine by rat liver. Carcinogenesis 17:1941–1947.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Melchior WB, Jr,
    2. Marques MM,
    3. Beland FA
    (1994) Mutations induced by aromatic amine DNA adducts in pBR322. Carcinogenesis 15:889–899.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Paigen B,
    2. Yarfitz S,
    3. Tabron D
    (1984) Urinary glucuronidase and arylsulfatases in identical twins of bladder cancer patients. Cancer Res 44:3624–3626.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Skinner DG,
    2. Lieskovsky G
    1. Ross RK,
    2. Paganini-Hill A,
    3. Henderson BE
    (1988) Epidemiology of bladder cancer. in Diagnosis and Management of Genitourinary Cancer, eds Skinner DG, Lieskovsky G (W.B. Saunders Co. Philadelphia), pp 23–31.
  24. ↵
    1. Rothman N,
    2. Talaska G,
    3. Hayes R,
    4. Bhatnagar V,
    5. Bell D,
    6. Lakshmi V,
    7. Kashyap S,
    8. Dosemeci M,
    9. Kashyap R,
    10. Hsu F,
    11. Jaeger M,
    12. Hirvonen A,
    13. Parikh D,
    14. Davis B,
    15. Zenser T
    (1997) Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and urothelial cell DNA adducts in exposed workers. Cancer Epidemiol Biomarkers Prev 6:1039–1042.
    OpenUrlAbstract
  25. ↵
    1. Wachstein M
    (1955) Histochemical staining reactions of the normally functioning and abnormal kidney. J Histochem Cytochem 3:246–270.
    OpenUrlFREE Full Text
  26. ↵
    1. Watanabe H,
    2. Grubb JH,
    3. Sly WS
    (1990) The overexpressed human 46-kDa mannose-6-phosphate receptor mediates endocytosis and sorting of β-glucuronidase. Proc Natl Acad Sci USA 87:8036–8040.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Zenser TV,
    2. Mattammal MB,
    3. Davis BB
    (1978) Differential distribution of the mixed-function oxidase activities in rabbit kidney. J Pharmacol Exp Ther 207:719–725.
    OpenUrlFREE Full Text
View Abstract
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 27 (9)
Drug Metabolism and Disposition
Vol. 27, Issue 9
1 Sep 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Human and Escherichia coliβ-Glucuronidase Hydrolysis of Glucuronide Conjugates of Benzidine and 4-Aminobiphenyl, and their Hydroxy Metabolites
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Human and Escherichia coliβ-Glucuronidase Hydrolysis of Glucuronide Conjugates of Benzidine and 4-Aminobiphenyl, and their Hydroxy Metabolites

Terry V. Zenser, Vijaya M. Lakshmi and Bernard B. Davis
Drug Metabolism and Disposition September 1, 1999, 27 (9) 1064-1067;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Human and Escherichia coliβ-Glucuronidase Hydrolysis of Glucuronide Conjugates of Benzidine and 4-Aminobiphenyl, and their Hydroxy Metabolites

Terry V. Zenser, Vijaya M. Lakshmi and Bernard B. Davis
Drug Metabolism and Disposition September 1, 1999, 27 (9) 1064-1067;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
  • Gene expression profile of human intestinal epithelial cells
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics